Virtual Autopsy in Cardiology, Cardio- and Vascular-Surgery
1 other identifier
observational
50
1 country
1
Brief Summary
Today complex vascular and cardiological interventions are performed in severely ill patients. Autopsy is the reference standard for quality control for almost two centuries, but autopsy rates for patients dying in hospitals are decreasing rapidly. Virtual autopsy has shown to be a good alternative for classic autopsy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2015
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2015
CompletedFirst Submitted
Initial submission to the registry
June 16, 2015
CompletedFirst Posted
Study publicly available on registry
July 20, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2017
CompletedAugust 8, 2017
August 1, 2017
2.2 years
June 16, 2015
August 7, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Agreement of virtual autopsy and medical autopsy (inter-method agreement)
Diagnoses made by virtual autopsy will be compared to diagnoses made by classic autopsy.
1 week
Secondary Outcomes (1)
Quality evaluation (satisfaction of the clinicians evaluated by a standardized questionnaire)
2 weeks
Interventions
Comparison of post-mortem angiography/virtual autopsy and medical autopsy
Eligibility Criteria
Patients dying after a cardiological intervention or a cardio-/vascular surgery.
You may qualify if:
- years or older AND
- dying after a cardiological intervention or a cardio-/vascular surgery AND
- oral informed consent from next of kind
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf (UKE)
Hamburg, 20251, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dominic Wichmann, MD
Department of Intensive Care Medicine, University Medical Center Hamburg
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 16, 2015
First Posted
July 20, 2015
Study Start
May 1, 2015
Primary Completion
July 1, 2017
Study Completion
August 1, 2017
Last Updated
August 8, 2017
Record last verified: 2017-08